The DOI matches its Crossref record.
Severe Hyperglycemia: Effects of Rehydration on Endocrine Derangements and Blood Glucose Concentration
Abstract
Diabetic ketoacidosis is associated with an excess secretion of counterregulatory hormones. The effect of rehydration on these endocrine derangements before insulin administration is unknown. Therefore, we measured the effect of rehydration with hypoosmolal fluid (220 mosmol/kg) on blood glucose (BG), immunoreactive insulin (IRI), immunoreactive C-peptide (IRCP), immunoreactive glucagon (IRG), human pancreatic polypeptide (hPP), growth hormone (GH), prolactin (PRL), cortisol, aldosterone, renin (PRC), epinephrine, norepinepnrine, and parathyroid hormone (PTH) in ketoacidotic diabetic patients [pH 7.03 ± 0.05 (SEM); n = 8] and in patients (n = 2) with nonketotic hyperglycemia (BG, 29.8 mmol/L and 46.8 mmol/L). The cumulative net fluid balance after rehydration was 4364 ± 690 ml. Basal insulin was inappropriately low, and IRCP was below the normal range (1.5 ± 0.5 ng/ml). Serum osmolality fell during hypoosmolal rehydration (n = 9) from 335 ± 11 to 315 ± 9 mosmol/kg. Rehydration with hypoosmolal fluid with bicarbonate added at a pH of less than 7.2 induced a fall in BG ranging from 6.1 mmol/L to 22.6 mmol/L, or of 16.7% to 79.8% of the initial BG level, as well as a decrease in plasma lactate and urinary glucose. These effects were paralleled by a decrease in IRG, cortisol, epinephrine, norepinephrine, aldosterone, and PRC. No fall in BG was seen in one patient whose dehydrated state was maintained by infusion of isotonic saline. Low dose insulin treatment was initiated in all patients immediately when no further fall in blood glucose levels was achieved. We conclude that rehydration improves the metabolic situation in severe diabetic hyperglycemia and ketoacidosis by reducing (a) the availability of counterregulatory hormones and (b) peripheral insulin resistance on a cellular level. Thus, proper rehydration will support the beneficial action of simultaneous low dose insulin treatment in patients with severe hyperglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Management of Hyperglycemic Crises in Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., Barrett, E. J., Kreisberg, R. A., Malone, J. I., & Wall, B. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.131 · Cited by 710
Wolfsdorf, J. I., Glaser, N., Agus, M., Fritsch, M., Hanas, R., Rewers, A., Sperling, M. A., & Codner, E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12701 · Cited by 710
Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0165-1 · Cited by 461
Glaser, N., Fritsch, M., Priyambada, L., Rewers, A., Cherubini, V., Estrada, S., Wolfsdorf, J. I., & Codner, E. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13406 · Cited by 390
Diabetic ketoacidosis and hyperglycemic hyperosmolar state
Wolfsdorf, J. I., Allgrove, J., Craig, M. E., Edge, J., Glaser, N., Jain, V., Lee, W. W., Mungai, L. N., Rosenbloom, A. L., Sperling, M. A., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12165 · Cited by 371
Diabetic Ketoacidosis in Infants, Children, and Adolescents
Wolfsdorf, J., Glaser, N., & Sperling, M. A. (2006) · Diabetes Care · doi:10.2337/dc06-9909 · Cited by 362
Pasquel, F. J., & Umpierrez, G. E. (2014) · Diabetes Care · doi:10.2337/dc14-0984 · Cited by 345
The metabolic derangements and treatment of diabetic ketoacidosis
Flier, J. S., Moore, M. J., Foster, D. W., & McGarry, J. D. (1983) · New England Journal of Medicine · doi:10.1056/nejm198307213090307 · Cited by 318
ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents
Dunger, D. B. (2004) · Archives of Disease in Childhood · doi:10.1136/adc.2003.044875 · Cited by 321
Diabetic ketoacidosis in children and adolescents with diabetes
Wolfsdorf, J., Craig, M. E., Daneman, D., Dunger, D., Edge, J., Lee, W., Rosenbloom, A., Sperling, M., & Hanas, R. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00569.x · Cited by 313
The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management
Nyenwe, E. A., & Kitabchi, A. E. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.007 · Cited by 309
Dunger, D. B., Sperling, M. A., Acerini, C. L., Bohn, D. J., Daneman, D., Danne, T. P. A., Glaser, N. S., Hanas, R., Hintz, R. L., Levitsky, L. L., et al. (2004) · Pediatrics · doi:10.1542/peds.113.2.e133 · Cited by 296
Management of Hyperglycemic Crises
Fayfman, M., Pasquel, F. J., & Umpierrez, G. E. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.12.011 · Cited by 278
Diabetic Ketoacidosis: Risk Factors and Management Strategies
Umpierrez, G. E., & Kitabchi, A. E. (2003) · Treatments in Endocrinology · doi:10.2165/00024677-200302020-00003 · Cited by 204
Hepatic glucose metabolism in humans—its role in health and disease
Roden, M., & Bernroider, E. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(03)00031-9 · Cited by 201
Alteration of Glucose Homeostasis in V1a Vasopressin Receptor-Deficient Mice
Aoyagi, T., Birumachi, J.-I., Hiroyama, M., Fujiwara, Y., Sanbe, A., Yamauchi, J., & Tanoue, A. (2007) · Endocrinology · doi:10.1210/en.2006-1315 · Cited by 113
Review of evidence for adult diabetic ketoacidosis management protocols
Tran, T. T. T., Pease, A., Wood, A. J., Zajac, J. D., Mårtensson, J., Bellomo, R., & Ekinci, E. I. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00106 · Cited by 97
PERNET, A., JOHNSTON, D. G., HAMMOND, V., ØRSKOV, H., & ALBERTI, K. G. M. M. (1986) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1986.tb01347.x · Cited by 4
Metadata
- Authors
- Waldhäusl, W., Kleinberger, G., Korn, A., Dudczak, R., Bratusch-Marrain, P., & Nowotny, P.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1979-06-01
- Volume
- 28
- Issue
- 6
- Pages
- 577-584
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2035617279
- Cited by
- 201
- References
- 0
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.